Imfinzi (durvalumab) supply for hospitals & distributors

PD-L1 immune checkpoint inhibitor (monoclonal antibody) · AstraZeneca

Imfinzi (durvalumab) is AstraZeneca's anti-PD-L1 antibody for intravenous infusion. It is used in lung, biliary tract, liver and endometrial cancers, sometimes together with tremelimumab (Imjudo) or chemotherapy.

اقرأ هذه الصفحة بالعربية

Prescription-only medicine. No prices are published. Supply is to hospitals, distributors, pharmacies and physicians against a valid prescription or purchase order. This page is product information, not medical advice.

Product facts

Active substancedurvalumab

ClassPD-L1 immune checkpoint inhibitor (monoclonal antibody)

Manufacturer (marketing authorisation holder)AstraZeneca

RouteIntravenous infusion

Strengths and presentation

120 mg/2.4 mL (50 mg/mL) concentrate for solution for infusion
500 mg/10 mL (50 mg/mL) concentrate for solution for infusion

Approved indications (EMA / FDA label summary)

Unresectable stage III NSCLC after platinum-based chemoradiation
Perioperative treatment of resectable NSCLC (label-dependent)
Extensive-stage and limited-stage small cell lung cancer
Biliary tract cancer, with gemcitabine and cisplatin
Unresectable hepatocellular carcinoma (with tremelimumab) and dMMR endometrial cancer (label-dependent)

Short label summary only. Approved indications differ by country and line of therapy; the national label in the destination country governs.

Storage and cold chain

Store refrigerated at 2–8 °C in the original carton to protect from light
Do not freeze; do not shake
Shipped in validated cold-chain packaging with temperature data logging

How we supply

Original manufacturer packs only — sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.
Batch number and expiry confirmed in writing before dispatch; every pack is traceable to its batch.
Documents with every consignment: commercial invoice, batch / CoA information from the source, and packing list.
Validated 2–8 °C cold-chain shipping with a temperature data logger from origin to handover.
Named-patient and special-import support: we prepare the paperwork your hospital or importer needs for the local regulator.

Procurement notes

Imfinzi is commonly dosed at 1500 mg flat dose, which hospital pharmacies usually build from three 500 mg vials. Lower-weight patients may need 120 mg vials as well; we quote the combination that fits the protocol.

Who we supply

Hospital pharmacy and procurement departments
Licensed pharmaceutical distributors and importers
Oncology and haematology centres
Treating physicians arranging named-patient supply

Markets served

United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq. Import into each country follows that country's regulator (for example MOHAP / DoH / DHA, SFDA, MoPH, Kuwait MOH, Oman MOH, NHRA) — we work with the receiving institution's import route.

Frequently asked questions

Can you supply Imfinzi with Imjudo (tremelimumab)?

Yes, where the protocol is the STRIDE regimen both products can be sourced and shipped together in one cold-chain consignment.

Which Imfinzi vial do hospitals order most?

The 500 mg/10 mL vial, because the common flat dose is built from 500 mg units. 120 mg vials are available for weight-based dosing.

Is the Imfinzi you supply an original manufacturer pack?

Yes. We supply Imfinzi only in the original AstraZeneca pack, sourced from licensed wholesalers in Türkiye and Europe, never repackaged or relabelled.

Which documents come with a consignment?

Commercial invoice, batch / CoA information from the source and a packing list, with batch number and expiry for every pack. Additional documents requested by your importer can be prepared.

Do you supply the UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain and Iraq?

Yes — to hospitals, distributors and licensed centres in these countries, through the import or named-patient route accepted by the destination country's regulator.

How do I get a quote for Imfinzi?

Send a supply inquiry on WhatsApp with strength, quantity, country and institution. We reply with a written quote, availability and expiry; we do not publish prices on the site.

Send a supply inquiry

Tell us the product, strength, quantity, destination country and the receiving institution. We reply with availability, batch/expiry and the documentation set — and a written quote. We do not sell to the public.

Send a supply inquiry

Other medicines we supply to the Gulf

Sources

EMA — Imfinzi EPAR / SmPC

Reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-11-04